https://www.selleckchem.com/pr....oducts/pemigatinib-i
ing were observed. Minor complications, mostly hematomas, occurred in 62 patients (7.3%), but they required no further treatment. CONCLUSION Brachial artery access expands our capability to perform complex procedures by allowing us to reach arterial targets in all territories. Complications of brachial vascular access are gradually decreasing together with the decrease of the crossing profile of the devices used in practice. However, when they occur, they often require surgical treatment. The growing experience of the tea
Like
Comment
Share
